U.S. stocks finished narrowly mixed on Friday, closing out a volatile week on a steadier note as a pullback in Treasury yields helped support technology shares. The Nasdaq Composite led the way, while the S&P 500 edged higher and the Dow slipped modestly. The gains capped a stretch dominated by the Federal Reserve, which earlier in the week raised interest rates for the first time since 2023, leaving investors to weigh a stabilizing bond market against lingering questions about inflation and the path ahead.
What Moved Markets
The tech-heavy Nasdaq Composite added 104.25 points, or 0.39 percent, to close at 26,522.55, benefiting from renewed appetite for large-cap technology and semiconductor names. The S&P 500 rose 12.74 points, or 0.17 percent, to end at 7,650.50. The Dow Jones Industrial Average was the lone laggard, giving back 97.30 points, or 0.19 percent, to finish at 51,680.74.
The main driver was a retreat in Treasury yields, which had climbed toward the 5 percent level following Wednesday’s rate hike. As yields eased and oil prices calmed after a stretch of choppy trading, some of the pressure on equities lifted, allowing growth-oriented shares to recover. Investors also appeared more comfortable that recent inflation and energy concerns may be contained for now, which encouraged buying in beaten-down corners of the market even as the blue-chip Dow drifted lower.
Notable Movers
Core & Main (CNM) climbed 4.21 percent, supported by improving broader sentiment following the Fed decision and analyst optimism after the water infrastructure supplier’s recent earnings beat and share pullback.
Flowserve (FLS) advanced 3.13 percent after the industrial machinery maker named longtime finance executive Brian Ezzell as its next chief financial officer, a leadership move investors viewed favorably.
Strategy (MSTR) rose 2.78 percent amid a broad rebound in cryptocurrency-linked stocks, helped by a relief rally in digital assets tied to legislative progress in Washington.
On the downside, Xenon Pharmaceuticals (XENE) tumbled 22.24 percent after the drugmaker voluntarily paused new patient enrollment in its late-stage trials of azetukalner, an experimental epilepsy treatment, raising concern about the timeline for the closely watched program.
Looking Ahead
With the Fed meeting behind them, investors will turn their attention to next week’s economic calendar and the resumption of corporate earnings. General Mills and Cintas are among the companies scheduled to report, offering fresh reads on consumer demand and business spending. The direction of Treasury yields and oil prices is likely to remain front and center, as both have driven much of the recent swing in sentiment. For retail investors, the takeaway from a choppy week is that markets are still adjusting to a higher-rate environment, and patience through the volatility may prove more useful than chasing day-to-day moves.